FDA Inspection
UCB Pharma S.A.UCB Pharma S.A. – FDA Inspection, Apr 21, 2023
Record Details
This FDA Inspection record concerns UCB Pharma S.A., with an inspection on April 21, 2023, issued by the Office of Inspections and Investigations.
- Company
- UCB Pharma S.A.
- Inspection Date
- April 21, 2023
View Company Profile
ID · 9be817f5-ce00-46cd-81a9-df3f6367f9ac
Inspection Facts
- Inspection number
- 1208307
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of UCB Pharma S.A.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| June 4, 2026 | Not classified | Office of Inspections and Investigations | Compliance: Devices |
| February 1, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 25, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 27, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 11, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for UCB Pharma S.A.
- FDA Inspection 1323186 - 2026-06-04
- FDA Inspection 1247808 - 2024-02-01
- FDA Inspection 1170317 - 2021-11-25
- FDA Inspection 1013309 - 2017-01-27
- FDA Inspection 946302 - 2015-09-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.